207 related articles for article (PubMed ID: 38344334)
1. The management of
Deac IŞ; Ofrim AM; Fărcaş RA; Grad S; Popa ŞL; Dumitraşcu DL
Med Pharm Rep; 2024 Jan; 97(1):5-11. PubMed ID: 38344334
[No Abstract] [Full Text] [Related]
2. Management of Clostridioides difficile infection in adults and challenges in clinical practice: review and comparison of current IDSA/SHEA, ESCMID and ASID guidelines.
Bishop EJ; Tiruvoipati R
J Antimicrob Chemother; 2022 Dec; 78(1):21-30. PubMed ID: 36441203
[TBL] [Abstract][Full Text] [Related]
3. European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults.
van Prehn J; Reigadas E; Vogelzang EH; Bouza E; Hristea A; Guery B; Krutova M; Norén T; Allerberger F; Coia JE; Goorhuis A; van Rossen TM; Ooijevaar RE; Burns K; Scharvik Olesen BR; Tschudin-Sutter S; Wilcox MH; Vehreschild MJGT; Fitzpatrick F; Kuijper EJ;
Clin Microbiol Infect; 2021 Dec; 27 Suppl 2():S1-S21. PubMed ID: 34678515
[TBL] [Abstract][Full Text] [Related]
4. Controversies in the Prevention and Treatment of
Bainum TB; Reveles KR; Hall RG; Cornell K; Alvarez CA
Microorganisms; 2023 Feb; 11(2):. PubMed ID: 36838352
[No Abstract] [Full Text] [Related]
5. Clinical Practice Guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 Focused Update Guidelines on Management of Clostridioides difficile Infection in Adults.
Johnson S; Lavergne V; Skinner AM; Gonzales-Luna AJ; Garey KW; Kelly CP; Wilcox MH
Clin Infect Dis; 2021 Sep; 73(5):755-757. PubMed ID: 34492699
[TBL] [Abstract][Full Text] [Related]
6. Clinical Practice Guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 Focused Update Guidelines on Management of Clostridioides difficile Infection in Adults.
Johnson S; Lavergne V; Skinner AM; Gonzales-Luna AJ; Garey KW; Kelly CP; Wilcox MH
Clin Infect Dis; 2021 Sep; 73(5):e1029-e1044. PubMed ID: 34164674
[TBL] [Abstract][Full Text] [Related]
7. Clostridioides Difficile: A Concise Review of Best Practices and Updates.
Yakout A; Bi Y; Harris DM
J Prim Care Community Health; 2024; 15():21501319241249645. PubMed ID: 38726585
[TBL] [Abstract][Full Text] [Related]
8. European Practice for CDI Treatment.
Fitzpatrick F; Brennan R; van Prehn J; Skally M; Brady M; Burns K; Rooney C; Wilcox MH
Adv Exp Med Biol; 2024; 1435():57-84. PubMed ID: 38175471
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of Fecal Microbiota Transplantation for First Recurrent Clostridioides difficile Infection.
Aby ES; Vaughn BP; Enns EA; Rajasingham R
Clin Infect Dis; 2022 Oct; 75(9):1602-1609. PubMed ID: 35275989
[TBL] [Abstract][Full Text] [Related]
10. Antibiotic Therapies for Clostridioides difficile Infection in Children.
Gonzales-Luna AJ; Carlson TJ; Garey KW
J Pediatric Infect Dis Soc; 2021 Nov; 10(Supplement_3):S52-S57. PubMed ID: 34791393
[TBL] [Abstract][Full Text] [Related]
11. Is Three Company or a Crowd? Comparing and Contrasting U.S. and European
Jones J; Pradhan A; Pizzuti ME; Bland CM; Bookstaver PB
Antibiotics (Basel); 2022 Sep; 11(9):. PubMed ID: 36140026
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of Treatment Regimens for Clostridioides difficile Infection: An Evaluation of the 2018 Infectious Diseases Society of America Guidelines.
Rajasingham R; Enns EA; Khoruts A; Vaughn BP
Clin Infect Dis; 2020 Feb; 70(5):754-762. PubMed ID: 31001619
[TBL] [Abstract][Full Text] [Related]
13. Evolution of clinical guidelines for antimicrobial management of
Chaar A; Feuerstadt P
Therap Adv Gastroenterol; 2021; 14():17562848211011953. PubMed ID: 33995583
[No Abstract] [Full Text] [Related]
14. Impact of Updated Clinical Practice Guidelines on Outpatient Treatment for
Dubberke ER; Puckett JT; Obi EN; Kamal-Bahl S; Desai K; Stuart B; Doshi JA
Open Forum Infect Dis; 2022 Oct; 9(10):ofac435. PubMed ID: 36267250
[TBL] [Abstract][Full Text] [Related]
15. [Clostridioides difficile: updated recommendations].
Barbut F; Eckert C; Lalande V; Le Neindre K; Couturier J
Rev Prat; 2022 Sep; 72(7):703-709. PubMed ID: 36511953
[TBL] [Abstract][Full Text] [Related]
16. Management of
Saha S; Khanna S
Therap Adv Gastroenterol; 2019; 12():1756284819847651. PubMed ID: 31105766
[No Abstract] [Full Text] [Related]
17. Fidaxomicin vs Vancomycin for the Treatment of a First Episode of Clostridium Difficile Infection: A Meta-analysis and Systematic Review.
Al Momani LA; Abughanimeh O; Boonpheng B; Gabriel JG; Young M
Cureus; 2018 Jun; 10(6):e2778. PubMed ID: 30112254
[TBL] [Abstract][Full Text] [Related]
18. Update of treatment algorithms for Clostridium difficile infection.
Ooijevaar RE; van Beurden YH; Terveer EM; Goorhuis A; Bauer MP; Keller JJ; Mulder CJJ; Kuijper EJ
Clin Microbiol Infect; 2018 May; 24(5):452-462. PubMed ID: 29309934
[TBL] [Abstract][Full Text] [Related]
19. The potential for emerging therapeutic options for Clostridium difficile infection.
Mathur H; Rea MC; Cotter PD; Ross RP; Hill C
Gut Microbes; 2014; 5(6):696-710. PubMed ID: 25564777
[TBL] [Abstract][Full Text] [Related]
20. Current management of Clostridioides (Clostridium) difficile infection in adults: a summary of recommendations from the 2017 IDSA/SHEA clinical practice guideline.
Ma J; Dubberke E
Pol Arch Intern Med; 2019 Mar; 129(3):189-198. PubMed ID: 30457126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
